Physiology of coronary vasomotricity and implications in coronary pathology;Physiologie de la vasomotricité coronaire et implications en pathologie coronaire

Medecine Therapeutique - Cardio

Volumn 1, Issue 1, 2005, Pages 17-27

  Elbaz, Meyer ^a  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPRENALINE; METHYLERGOMETRINE MALEATE;

ATHEROSCLEROSIS; CARDIOVASCULAR AUTOREGULATION; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY SPASM; CORONARY RISK; GENETIC RISK; HUMAN; NEUROMODULATION; NONHUMAN; PROGNOSIS; PROVOCATION TEST; RACE DIFFERENCE; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; ST SEGMENT; SYSTEMATIC REVIEW; VASCULAR ENDOTHELIUM; VASOMOTOR REFLEX;

EID: 16844382604     PISSN: None     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. Young MA, Vatner SF. Regulation of large coronaries arteries. Circ Res 1986; 59: 579-96.
2. Mohrman DE, Feigl EO. Competition between sympathetic vasoconstriction and metabolic vasodilation in the canine coronary circulation. Circ Res 1978; 42: 79-86.
3. Harrison DG, Bates JN. The nitrovasolators: New ideas about old drugs. Circulation 1993; 87: 1461-7.
4. Holtz J, Giesler M, Bassenge E. Two dilatory mechanisms of anti-anginal drugs on epicardial coronary arteries in vivo: Indirect, flow dependant, endothelium-mediated and direct smooth muscle relaxation. Z Cardiol 1983; 108: 98-106.
5. Kato M, Shiode N, Yamagata T, et al. Bradykinine induced dilation of human epicardial and resistance coronary arteries in vivo: effect of inhibition of nitric oxide synthesis. Heart 1997; 78: 493-8.
6. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in relaxation of smooth muscle by acetylcholine. Nature 1980; 228: 373-6.
7. Luscher TF. Endothelium-derived nitric oxide: the endogenous nitrovasodilator in the human cardiovascular system. Eur Heart J 1991; 12: 2-11.
8. Ferrer M, Marin J, Encabo A, et al. Role of K+ channels and sodium pump in the vasodilation induced by acetylcholine, nitric oxide, and cyclic GMP in the rabbit aorta. Gen Pharmacol 1999; 33: 35-41.
9. Feletou M, Vanhoute PM. Endothelium-derived hyperpolarizing factor. Clin Exp Pharmacol Physiol 1996; 23: 1082-90.
10. Gerová M, Barta E, Gero J. Sympathetic control of major coronary artery diameter in the dog. Circ Res 1979; 44: 459-67.
11. Zeiher AM, Drexler H, Wollschlaeger H, et al. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J Am Coll Cardiol 1989; 14: 1181-90.
12. Haws CW, Green LS, Burgess MJ, Abildskov JA. Effects of cardiac sympathetic nerve stimulation on regional coronary blood flow. Am J Physiol 1987; 252: H269-H274.
13. Young MA, Knight DR, Vatner SF. Autonomic control of large coronary arteries and resistance vessels. Prog Cardiovasc Dis 1987; 30:211-34.
14. Heusch G, Deussen A, Schipke J, et al. Alpha1-and alpha2-adrenoceptor- mediated vasoconstriction of large and small canine coronary arteries in vivo. J Card Pharmacol 1984; 6: 961-8.
15. Kovach JA, Gottdiener JS, Verrier RL.Vagal modulation of epicardial coronary artery size in dogs. À two-dimensional intravascular ultrasound study. Circulation 1995; 92: 2291-8.
16. Zeiher AM, Drexler H, Wollschläger H, et al. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991; 83: 391-401.
17. Crea F, Von Arnim T, Allwork SP, et al. Failure of experimental atherosclerosis to sensitize coronary arteries to spasm in hypercholesterolemic rabbits. Am Heart J 1985; 109: 491-7.
18. Miyata K, Shimokawa H, Yamawaki T, et al. Endothelial vasodilator function is preserved at the spastic/inflammatory coronary lesions in pigs. Circulation 1999; 100: 1432-7.
19. Kandabashi T, Shimokawa H, Miyata K, et al. Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta. Circulation 2000; 101: 1319-23.
20. Hermsmeyer K, Miyagawa K, Kelley ST, et al. Reactivity-based coronary vasospasm independent of atherosclerosis in rhesus monkeys. J Am Coll Cardiol 1997; 29: 671-80.
21. Minshall RD, Pavcnik D, Browne DL, et al. Nongenomic vasodilator action of progesterone on primate coronary arteries. J Appl Physiol 2002; 92: 701-8.
22. Miki T, Suzuki M, Shibasaki T, et al. Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1. Nat Med 2002; 8: 466-72.
23. Cines DB, Pollak ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91: 3527-61.
24. Abrams J. Role of endothelial dysfunction in coronary artery disease. Am J Cardiol 1997; 79: 2-9.
25. Treasure CB, Klein JL, Weintraub WS, et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995; 332: 481-7.
26. Anderson TJ, Meredith IT, Yeung AC, et al. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995; 332: 488-93.
27. Mancini GBJ, Henry CC, Macaya C, et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing Endothelial Dysfunction) Study. Circulation 1996; 94: 258-65.
28. Wu KK, Thiagarajan P. Role of endothelium in thrombosis and hemostasis. Annu Rev Med 1996; 47: 315-31.
29. Britten MB, Zeiher AM, Schachinger V. Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options. J Intern Med 1999; 245: 315-27.
30. Fukuda Y, Teragawa H, Matsuda K, et al. Tetrahydrobiopterin improves coronary endothelial function, but does not prevent coronary spasm in patients with vasospastic angina. Circ J 2002; 66: 58-62.
31. Egashira K, Inou T, Yamada A, et al. Preserved endothelium-dependent vasodilation at the vasospastic site in patients with variant angina. J Clin Invest 1992; 89: 1047-52.
32. Egashira K, Katsuda Y, Mohri M, et al. Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina. J Am Coll Cardiol 1996; 27: 1444-55.
33. Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235-41.
34. Vogel RA. Measurement of endothelial function by brachial artery flow-mediated vasodilation. Am J Cardiol 2001; 88: 31E; E.
35. Monnink SH, Tio RA, van Boven AJ, et al. The role of coronary endothelial function testing in patients suspected for angina pectoris. Int J Cardiol 2004; 96: 123-9.
36. Lanza GA, Pedrotti P, Pasceri V, et al. Autonomic changes associated with spontaneous coronary spasm in patients with variant angina. J Am Coll Cardiol 1996; 28: 1249-56.
37. Yasue H, Touyama M, Shimamoto M, et al. Role of autonomic nervous system in the pathogenesis of Prinzmetal's variant form of angina. Circulation 1974; 50: 534-9.
38. Choi SS, Lim YJ, Bahk JH, et al. Coronary artery spasm induced by carotid sinus stimulation during neck surgery. Br J Anaesth 2003; 90: 391-4.
39. Ricci DR, Orlick AE, Cipriano PR, et al. Altered adrenergic activity in coronary arterial spasm: Insight into mechanism based on study of coronary hemodynamics and the electrocardiogram. Am J Cardiol 1979; 43: 1073-9.
40. Cocks TM, Angus JA. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature 1983; 305: 627-30.
41. Rasmussen K, Bagger JP, Bottzauw J, et al. Prevalence of vasospastic ischaemia induced by the cold pressor test or hyperventilation in patients with severe angina. Eur Heart J 1984; 5: 354-61.
42. Nabel EG, Ganz P, Gordon JB, et al. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation 1988; 77: 43-52.
43. Wang CH, Lee CC, Cherng WJ. Coronary vasospasm induced during isoproterenol head-up tilt test. Am J Cardiol 1997; 80: 1508-10.
44. Winniford MD, Filipchuk N, Hillis LD. Alpha-adrenergic blockade for variant angina: A long-term, double-blind, randomized trial. Circulation 1983; 67: 1185-8.
45. Pop C, Metz D, Matei M. Infarctus du myocarde du postpartum induit par le Parlodel. Arch Mal Cœur Vx 1998; 91: 1171-4.
46. Saff R, Nahhas A, Fink JN. Myocardial infarction induced by coronary vasospasm after self-administration of epinephrine. Ann Allergy 1993; 70: 396-8.
47. Altura BM, Altura BT, Carella A. Ethanol produces coronary vasospasm: Evidence for a direct action of ethanol on vascular muscle. Br J Pharmacol 1983; 78: 260-2.
48. Kalsner S. Cocaine sensitization of coronary artery contractions: Mechanism of drug-induced spasm. J Pharmacol Exp Ther 1993; 264: 1132-40.
49. Wilbert-Lampen U, Seliger C, Zilker T, et al. Cocaine increases the endothelial release of immunoreactive endothelin and its concentrations in human plasma and urine: Reversal by coincubation with sigma-receptor antagonists. Circulation 1998; 98: 385-90.
50. Sueda S, Fukuda H, Watanabe K, et al. Magnesium deficiency in patients with recent myocardial infarction and provoked coronary artery spasm. Jpn Circ J 2001; 65: 643-8.
51. Liu Y, Terata K, Chai Q, et al. Peroxynitrite inhibits Ca2+ activated K+ channel activity in smooth muscle of human coronary arterioles. Circ Res 2002; 91: 1070-6.
52. Arbustini E, Dal Bello B, Morbini P, et al. Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart 1999; 82: 269-72.
53. Miwa K, Kishimoto C, Nakamura H, et al. Increased oxidative stress with elevated serum thioredoxin level in patients with coronary spastic angina. Clin Cardiol 2003; 26: 177-81.
54. Specchia G, De Servi S, Falcone C, et al. Coronary arterial spasm as a cause of exercise-induced ST-segment elevation in patients with variant angina. Circulation 1979; 59: 948-54.
55. Freedman SB, Richmond DR, Kelly DT. Clinical studies of patients with coronary spasm. Am J Cardiol 1983; 52: 67A-671.
56. Fuller CM, Raizner AE, Chahine RA, et al. Exercise-induced coronary arterial spasm: Angiographic demonstration, documentation of ischemia by myocardial scintigraphy and results of pharmacologic intervention. Am J Cardiol 1980; 46: 500-6.
57. Specchia G, De Servi S, Falcone C, et al. Coronary arterial spasm as a cause of exercise-induced ST-segment elevation in patients with variant angina. Circulation 1979; 59: 948-54.
58. Bertrand ME, Lablanche JM, Tilmant PY, et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation 1982; 65: 1299-306.
59. Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: Differences between Japanese and Caucasian patients. J Am Coll Cardiol 1999; 33: 1442-52.
60. Pristipino C, Beltrame JF, Finocchiaro ML, et al. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 2000; 101: 1102-8.
61. Gould SE, Hayashi T, Tashiro T, et al. Coronary heart disease and stroke. Atherosclerosis in Japanese men in Hiroshima, Japan and Honolulu, Hawaii. Arch Path 1972; 93: 98-102.
62. Trombold JC, Moellering RC, Kagan A. Epidemiological aspects of coronary heart disease and cerebrovascular disease: The Honolulu Heart Program. Hawaii Med J 1966; 25: 231-4.
63. Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81: 491-7.
64. Zeiher AM, Drexler H, Saurbier B, et al. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 1993; 92: 652-62.
65. Suwaidi A, Hamasaki S, Higano ST, Nishimura RA, Holmes DRJ, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101: 948-54.
66. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101: 1899-906.
67. Quyyumi AA. Prognostic value of endothelial function. Am J Cardiol 2003; 91: 19H-124.
68. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 1993; 87: 76-9.
69. Yoshimura M, Yasue H, Nakayama M, et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 1998; 103: 65-9.
70. Nakayama M, Yasue H, Yoshimura M, et al. T-786→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with myocardial infarction, especially without coronary organic stenosis. Am J Cardiol 2000; 86: 628-34.
71. Ito T, Yasue H, Yoshimura M, et al. Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm. Hum Genet 2002; 110: 89-94.
72. Shimokawa H, Seto M, Katsumata N, et al. Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res 1999; 43: 1029-39.
73. Shimokawa H. Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. J Cardiovasc Pharmacol 2002; 39: 319-27.
74. Fukata Y, Amano M, Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of nonmuscle cells. Trends Pharmacol Sci 2001; 22: 32-9.
75. Yasue H, Takizawa A, Nagao M, et al. Long-term prognosis for patients with variant angina and influential factors. Circulation 1988; 78: 1-9.
76. Shimokawa H, Nagasawa K, Irie T, et al. Clinical characteristics and long-term prognosis of patients with variant angina. A comparative study between western and Japanese populations. Int J Cardiol 1988; 18: 331-49.
77. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-36.
78. Heupler FA, Proudfit WL, Razavi M, et al. Ergonovine maleate provocative test for coronary arterial spasm. Am J Cardiol 1978; 41: 631-40.
79. Okumura K, Yasue H, Matsuyama K, Goto K, Miyagi H, Ogawa H. Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm. J Am Coll Cardiol 1988; 12(4): 883-8.
80. Egashira K, Tomoike H, Yamamoto Y, et al. Histamine-induced coronary spasm in regions of intimal thickening in miniature pigs: Role of serum cholesterol and spontaneous or induced intimal thickening. Circulation 1986; 74: 826-37.
81. Reddy KG, Nair RN, Sheehan HM, et al. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol 1994; 23: 833-43.
82. Sueda S, Kohno H, Fukuda H, et al. Limitations of medical therapy in patients with pure coronary spastic angina. Chest 2003; 123: 380-6.
83. Lanza GA, Colonna G, Pasceri V, et al. Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol 1999; 84: 854; 6A8.
84. Suzuki J, Watanabe K, Tsuruoka T, et al. Beneficial effects of betaxolol, a selective antagonist of beta-1 adrenoceptors, on exercise-induced myocardial ischemia in patients with coronary vasospasm. Int J Cardiol 2003; 91: 227-32.
85. Mohri M, Shimokawa H, Hirakawa Y, et al. Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm. J Am Coll Cardiol 2003; 41: 15-9.
86. Takagi S, Goto Y, Hirose E, et al. Successful treatment of refractory vasospastic angina with corticosteroids: coronary arterial hyperactivity caused by local inflammation? Circ J 2004; 68: 17-22.